Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Erectile Dysfunction

  Free Subscription


Articles published in J Urol

Retrieve available abstracts of 71 articles:
HTML format
Text format



Single Articles


    February 2019
  1. SEFTEL AD
    Re: A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Utility of Tacrolimus (FK506) for the Prevention of Erectile Dysfunction following Bilateral Nerve-Sparing Radical Prostatectomy.
    J Urol. 2019;201:212.
    PubMed     Text format    


  2. SEFTEL AD
    Re: Alcohol Intake and Risk of Erectile Dysfunction: .
    J Urol. 2019;201:212.
    PubMed     Text format    


  3. SEFTEL AD
    Re: The Risk of Erectile Dysfunction following Pelvic Angiographic Embolization in Pelvic Fracture Patients: .
    J Urol. 2019;201:211-212.
    PubMed     Text format    


    November 2018
  4. KAPLAN SA
    Re: Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
    J Urol. 2018;200:918-921.
    PubMed     Text format    


    October 2018
  5. SEFTEL AD
    Re: Real-World Observational Results from a Database of 48 Million Men in the United States: Relationship of Cardiovascular Disease, Diabetes Mellitus and Depression with Age and Erectile Dysfunction.
    J Urol. 2018;200:680-682.
    PubMed     Text format    


    September 2018
  6. SEFTEL AD
    Re: The Effect of Low-Intensity Extracorporeal Shockwave Therapy in an Obesity-Associated Erectile Dysfunction Rat Model.
    J Urol. 2018;200:482.
    PubMed     Text format    


  7. SEFTEL AD
    Re: Abnormal Brain Structure as a Potential Biomarker for Venous Erectile Dysfunction: Evidence from Multimodal MRI and Machine Learning.
    J Urol. 2018;200:481-482.
    PubMed     Text format    


  8. SEFTEL AD
    Re: Efficacy and Safety of Tadalafil 5 mg Once Daily for the Treatment of Erectile Dysfunction after Robot-Assisted Laparoscopic Radical Prostatectomy: A 2-Year Follow-up.
    J Urol. 2018;200:481.
    PubMed     Text format    


  9. SEFTEL AD
    Re: The Role of Neutrophil-to-Lymphocyte Ratio in Men with Erectile Dysfunction-Preliminary Findings of a Real-Life Cross-Sectional Study.
    J Urol. 2018;200:480-482.
    PubMed     Text format    


    June 2018
  10. SEFTEL AD
    Re: Efficacy and Safety of MED2005, a Topical Glyceryl Trinitrate Formulation, in the Treatment of Erectile Dysfunction: A Randomized Crossover Study.
    J Urol. 2018;199:1378-1380.
    PubMed     Text format    


    May 2018
  11. BURNETT AL, Nehra A, Breau RH, Culkin DJ, et al
    Erectile Dysfunction: AUA Guideline.
    J Urol. 2018 May 7. pii: S0022-5347(18)43100-X. doi: 10.1016/j.juro.2018.
    PubMed     Text format     Abstract available


  12. SEFTEL AD
    Re: Erectile Dysfunction and Quality of Life in Men Receiving Methadone or Buprenorphine Maintenance Treatment. A Cross-Sectional Multicentre Study.
    J Urol. 2018;199:1095-1097.
    PubMed     Text format    


    February 2018
  13. KITREY ND, Vardi Y, Appel B, Shechter A, et al
    Low-intensity shockwave treatment for erectile dysfunction - how long does the effect last?
    J Urol. 2018 Feb 22. pii: S0022-5347(18)39376-5. doi: 10.1016/j.juro.2018.
    PubMed     Text format     Abstract available


  14. SEFTEL AD
    Re: Quality of Erections by Age Group in Men with Erectile Dysfunction.
    J Urol. 2018;199:328.
    PubMed     Text format    


  15. SEFTEL AD
    Re: Prognostic Value of Exercise Capacity among Men Undergoing Pharmacologic Treatment for Erectile Dysfunction: The FIT Project.
    J Urol. 2018;199:327-329.
    PubMed     Text format    


    December 2017
  16. SEFTEL AD
    Re: Factors Associated with Erectile Dysfunction and the Peyronie's Disease Questionnaire in Patients with Peyronie Disease.
    J Urol. 2017;198:1193-1194.
    PubMed     Text format    


  17. SEFTEL AD
    Re: Does any Association Exist between Chronic Obstructive Pulmonary Disease and Erectile Dysfunction? The DECODED Study.
    J Urol. 2017;198:1192-1194.
    PubMed     Text format    


    November 2017
  18. SEFTEL AD
    Re: Low-Intensity Shockwave Therapy Improves Hemodynamic Parameters in Patients with Vasculogenic Erectile Dysfunction: A Triplex Ultrasonography-Based Sham-Controlled Trial.
    J Urol. 2017;198:964.
    PubMed     Text format    


  19. SEFTEL AD
    Re: Male Sexual Function in New Zealand: A Population-Based Cross-Sectional Survey of the Prevalence of Erectile Dysfunction in Men Aged 40-70 Years.
    J Urol. 2017;198:963-965.
    PubMed     Text format    


    September 2017
  20. KAPLAN SA
    Re: Impact of Combination Therapy 5-Alpha Reductase Inhibitors (5-ARI) plus Alpha-Blockers (AB) on Erectile Dysfunction and Decrease of Libido in Patients with LUTS/BPH: A Systematic Review with Meta-Analysis.
    J Urol. 2017;198:457-458.
    PubMed     Text format    


    August 2017
  21. SEFTEL AD
    Re: Combination of Mesenchymal Stem Cell Injection with Icariin for the Treatment of Diabetes-Associated Erectile Dysfunction.
    J Urol. 2017;198:238.
    PubMed     Text format    


  22. SEFTEL AD
    Re: Subclinical Vascular Disease and Subsequent Erectile Dysfunction: The Multiethnic Study of Atherosclerosis (MESA).
    J Urol. 2017;198:236-237.
    PubMed     Text format    


  23. SEFTEL AD
    Re: Association between Treatment for Erectile Dysfunction and Death or Cardiovascular Outcomes after Myocardial Infarction.
    J Urol. 2017;198:236-238.
    PubMed     Text format    


  24. SEFTEL AD
    Re: Relationship between Age and Erectile Dysfunction Diagnosis or Treatment Using Real-World Observational Data in the USA.
    J Urol. 2017;198:235-236.
    PubMed     Text format    


    June 2017
  25. SEFTEL AD
    Re: Self-Reported Sitting Time and Prevalence of Erectile Dysfunction in Japanese Patients with Type 2 Diabetes Mellitus: The Dogo Study.
    J Urol. 2017;197:1534.
    PubMed     Text format    


  26. SEFTEL AD
    Re: Skin Autofluorescence (a Marker for Advanced Glycation End Products) and Erectile Dysfunction in Diabetes.
    J Urol. 2017;197:1533-1535.
    PubMed     Text format    


    May 2017
  27. SEFTEL AD
    Re: Prevalence of Use of Erectile Dysfunction Medication by Dutch Military Personnel between 2003 and 2012.
    J Urol. 2017;197:1333.
    PubMed     Text format    


    March 2017
  28. SEFTEL AD
    Re: Mirabegron Causes Relaxation of Human and Rat Corpus Cavernosum: Could it be a Potential Therapy for Erectile Dysfunction?
    J Urol. 2017;197.
    PubMed     Text format    


    February 2017
  29. ATALA A
    Re: Treatment of Diabetes Mellitus-Induced Erectile Dysfunction Using Endothelial Progenitor Cells Genetically Modified with Human Telomerase Reverse Transcriptase.
    J Urol. 2017;197:494.
    PubMed     Text format    


    January 2017
  30. KAPLAN SA
    Re: Finasteride, Not Tamsulosin, Increases Severity of Erectile Dysfunction and Decreases Testosterone Levels in Men with Benign Prostatic Hyperplasia.
    J Urol. 2017;197:221-222.
    PubMed     Text format    


    December 2016
  31. NANGIA AK
    Testosterone Replacement Should be Given to Men with Erectile Dysfunction: Con.
    J Urol. 2016 Dec 17. pii: S0022-5347(16)31775-X. doi: 10.1016/j.juro.2016.
    PubMed     Text format    


  32. CLAVIJO RI, Ramasamy R
    Testosterone Replacement Should be Given to Men with Erectile Dysfunction: Pro.
    J Urol. 2016 Dec 17. pii: S0022-5347(16)31774-8. doi: 10.1016/j.juro.2016.
    PubMed     Text format    


    November 2016
  33. SEFTEL AD
    Re: Vasculogenesis and Diabetic Erectile Dysfunction: How Relevant is Glycemic Control?
    J Urol. 2016;196:1588.
    PubMed     Text format    


  34. SEFTEL AD
    Re: The Effects of Adipose-Derived Stem Cells in a Rat Model of Tobacco-Associated Erectile Dysfunction.
    J Urol. 2016;196:1587-1588.
    PubMed     Text format    


    October 2016
  35. SEFTEL AD
    Re: Recovery of Baseline Erectile Function in Men following Radical Prostatectomy for High-Risk Prostate Cancer: A Prospective Analysis Using Validated Measures.
    J Urol. 2016;196:1228-30.
    PubMed     Text format    


    September 2016
  36. BOZORGMEHRI S, Fink HA, Parimi N, Canales B, et al
    Association of Sleep-Disordered Breathing With Erectile Dysfunction In Community-Dwelling Older Men.
    J Urol. 2016 Sep 30. pii: S0022-5347(16)31408-2. doi: 10.1016/j.juro.2016.
    PubMed     Text format     Abstract available


  37. SEFTEL AD
    Re: Vascular and Chronological Age in Men with Erectile Dysfunction: A Longitudinal Study.
    J Urol. 2016;196:857-8.
    PubMed     Text format    


  38. SEFTEL AD
    Re: A Nationwide Population-Based Cohort Study of Migraine and Organic-Psychogenic Erectile Dysfunction.
    J Urol. 2016;196:857.
    PubMed     Text format    


    August 2016
  39. SEFTEL AD
    Re: Six Months of Daily Treatment with Vardenafil Improves Parameters of Endothelial Inflammation and of Hypogonadism in Male Patients with Type 2 Diabetes and Erectile Dysfunction: A Randomized, Double-Blind, Prospective Trial.
    J Urol. 2016;196:518-9.
    PubMed     Text format    


  40. SEFTEL AD
    Re: Tadalafil 5 mg Once Daily for the Treatment of Erectile Dysfunction during a 6-Month Observational Study (EDATE): Impact of Patient Characteristics and Comorbidities.
    J Urol. 2016;196:515-6.
    PubMed     Text format    


  41. MOREY AF
    Re: The Vascular and Neurogenic Factors Associated with Erectile Dysfunction in Patients after Pelvic Fractures.
    J Urol. 2016;196:462-3.
    PubMed     Text format    


    July 2016
  42. KAPLAN SA, Griebling TL
    Re: The Co-Occurring Syndrome-Coexisting Erectile Dysfunction and Benign Prostatic Hyperplasia and Their Clinical Correlates in Aging Men: Results from the National Health and Nutrition Examination Survey.
    J Urol. 2016;196:190-1.
    PubMed     Text format    


    June 2016
  43. SEFTEL AD
    Re: Effect of Levitra on Sustenance of Erection (EROS): An Open-Label, Prospective, Multicenter, Single-Arm Study to Investigate Erection Duration Measured by Stopwatch with Flexible Dose Vardenafil Administered for 8 Weeks in Subjects with Erectile D
    J Urol. 2016;195:1854-6.
    PubMed     Text format    


    May 2016
  44. MOREY AF
    Re: Penile Prosthesis First and Replacement Surgeries: Analysis of Patient and Partner Satisfaction.
    J Urol. 2016;195:1510.
    PubMed     Text format    


  45. MOREY AF
    Re: The Prevention and Management of Noninfectious Complications of Penile Implants.
    J Urol. 2016;195:1509-10.
    PubMed     Text format    


  46. KITREY ND, Gruenwald I, Appel B, Shechter A, et al
    Penile Low Intensity Shock Wave Treatment is Able to Shift PDE5i Nonresponders to Responders: A Double-Blind, Sham Controlled Study.
    J Urol. 2016;195:1550-5.
    PubMed     Text format     Abstract available


    April 2016
  47. WHITSON JM, Murray KS, Thrasher JB
    Prostate Biopsy is Associated with an Increased Risk of Erectile Dysfunction.
    J Urol. 2016 Apr 8. pii: S0022-5347(16)30136-7. doi: 10.1016/j.juro.2016.
    PubMed     Text format    


  48. JAMNAGERWALLA J, Howard LE, Vidal AC, Moreira DM, et al
    The Association Between Phosphodiesterase Type-5 Inhibitors and Prostate Cancer: Results from the REDUCE Study.
    J Urol. 2016 Apr 5. pii: S0022-5347(16)30127-6. doi: 10.1016/j.juro.2016.
    PubMed     Text format     Abstract available


  49. SEFTEL AD
    Re: Intraoperative Decision-Making for Precise Penile Straightening during Inflatable Penile Prosthesis Surgery.
    J Urol. 2016;195.
    PubMed     Text format    


  50. SEFTEL AD
    Re: The Importance of Psychosexual Counselling in the Re-Establishment of Organic and Erotic Functions after Penile Prosthesis Implantation.
    J Urol. 2016;195.
    PubMed     Text format    


    March 2016
  51. SEFTEL AD
    Re: Erectile Dysfunction in 1050 Men following Extended (18 Cores) vs Saturation (28 Cores) vs Saturation plus MRI-Targeted Prostate Biopsy (32 Cores).
    J Urol. 2016;195:714-5.
    PubMed     Text format    


  52. SEFTEL AD
    Re: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
    J Urol. 2016;195:713-5.
    PubMed     Text format    


  53. SEFTEL AD
    Re: Unexpected Long-Term Improvements in Urinary and Erectile Function in a Large Cohort of Men with Self-Reported Outcomes following Radical Prostatectomy.
    J Urol. 2016;195:713-4.
    PubMed     Text format    


    February 2016
  54. CADEDDU JA
    Re: Urinary Incontinence and Erectile Dysfunction after Robotic versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial.
    J Urol. 2016;195:354.
    PubMed     Text format    


  55. MOREY AF
    Re: Prospective Evaluation of Postoperative Penile Rehabilitation: Penile Length/Girth Maintenance 1 Year following Coloplast Titan Inflatable Penile Prosthesis.
    J Urol. 2016;195:444.
    PubMed     Text format    


  56. EBERT AK
    Editorial Comment.
    J Urol. 2016;195:470.
    PubMed     Text format    


  57. RUBENWOLF P, Thomas C, Thuroff JW, Stein R, et al
    Sexual Function, Social Integration and Paternity of Males with Classic Bladder Exstrophy following Urinary Diversion.
    J Urol. 2016;195:465-70.
    PubMed     Text format     Abstract available


  58. HENRY GD, Karpman E, Brant W, Christine B, et al
    The Who, How and What of Real-World Penile Implantation in 2015: The PROPPER Registry Baseline Data.
    J Urol. 2016;195:427-33.
    PubMed     Text format     Abstract available


    January 2016
  59. LOEB S, Lambe M, Stattin P
    Re: Editorial Comment on Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma: D. F. Penson J Urol 2015;194:1710-1711.
    J Urol. 2016 Jan 16. pii: S0022-5347(15)05310-0. doi: 10.1016/j.juro.2015.
    PubMed     Text format    


  60. SEFTEL AD
    Re: Finasteride, Not Tamsulosin, Increases Severity of Erectile Dysfunction and Decreases Testosterone Levels in Men with Benign Prostatic Hyperplasia.
    J Urol. 2016;195:139.
    PubMed     Text format    


    December 2015
  61. PENSON DF
    Re: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
    J Urol. 2015;194:1710-1711.
    PubMed     Text format    


  62. SEFTEL AD
    Re: Increased Risk of Dementia in Patients with Erectile Dysfunction: A Population-Based, Propensity Score-Matched, Longitudinal Follow-up Study.
    J Urol. 2015;194:1708-1709.
    PubMed     Text format    


  63. SEFTEL AD
    Re: Sex Offenders Seeking Treatment for Sexual Dysfunction--Ethics, Medicine, and the Law.
    J Urol. 2015;194:1708.
    PubMed     Text format    


    November 2015
  64. PEYTON CC, Colaco MA, Kovell RC, Kim JH, et al
    Erectile Dysfunction is Predictive of Endothelial Dysfunction in a Well-Visit Population.
    J Urol. 2015 Nov 22. pii: S0022-5347(15)05259-3. doi: 10.1016/j.juro.2015.
    PubMed     Text format     Abstract available


  65. SEFTEL AD
    Re: Evaluation of Clinical Efficacy, Safety and Patient Satisfaction Rate after Low-Intensity Extracorporeal Shockwave Therapy for the Treatment of Male Erectile Dysfunction: An Australian First Open-Label Single-Arm Prospective Clinical Trial.
    J Urol. 2015;194:1364.
    PubMed     Text format    


  66. SILVA CN, Nunes KP, Torres FS, Cassoli JS, et al
    PnPP-19, a Synthetic and Nontoxic Peptide Designed from a Phoneutria nigriventer Toxin, Potentiates Erectile Function via NO/cGMP.
    J Urol. 2015;194:1481-90.
    PubMed     Text format     Abstract available


    October 2015
  67. LIN H, Dhanani N, Tseng H, Souza GR, et al
    Nanoparticle Improved Stem Cell Therapy for Erectile Dysfunction in a Rat Model of Cavernous Nerve Injury.
    J Urol. 2015 Oct 28. pii: S0022-5347(15)05149-6. doi: 10.1016/j.juro.2015.
    PubMed     Text format     Abstract available


    July 2015
  68. SEFTEL AD
    Re: A Randomised Controlled Trial of a Couples-Based Sexuality Intervention for Men with Localised Prostate Cancer and their Female Partners.
    J Urol. 2015;194:167-8.
    PubMed     Text format    


    May 2015
  69. ZILLI T, Miralbell R
    Re: Prophylactic Sildenafil Citrate Improves Select Aspects of Sexual Function in Men Treated with Radiotherapy for Prostate Cancer: M. J. Zelefsky, D. Shasha, R. D. Branco, M. Kollmeier, R. E. Baser, X. Pei, R. Ennis, R. Stock, N. Bar-Chama and J. P.
    J Urol. 2015 May 6. pii: S0022-5347(15)03228-0. doi: 10.1016/j.juro.2014.
    PubMed     Text format    


  70. KAPLAN SA
    Re: Patient-reported sexual outcomes after holmium laser enucleation of the prostate: a 3-year follow-up study.
    J Urol. 2015;193:1604-5.
    PubMed     Text format    


    April 2015
  71. SEFTEL AD
    Re: Effects of holmium laser enucleation of the prostate on sexual function.
    J Urol. 2015;193:1326-7.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Erectile Dysfunction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: